IL147563A0 - Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins - Google Patents

Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Info

Publication number
IL147563A0
IL147563A0 IL14756300A IL14756300A IL147563A0 IL 147563 A0 IL147563 A0 IL 147563A0 IL 14756300 A IL14756300 A IL 14756300A IL 14756300 A IL14756300 A IL 14756300A IL 147563 A0 IL147563 A0 IL 147563A0
Authority
IL
Israel
Prior art keywords
avermectins
ratio
streptomyces avermitilis
gene directing
avermitilis gene
Prior art date
Application number
IL14756300A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL147563A0 publication Critical patent/IL147563A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14756300A 1999-08-12 2000-07-24 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins IL147563A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14864599P 1999-08-12 1999-08-12
PCT/IB2000/001017 WO2001012821A1 (en) 1999-08-12 2000-07-24 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (1)

Publication Number Publication Date
IL147563A0 true IL147563A0 (en) 2002-08-14

Family

ID=22526696

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14756300A IL147563A0 (en) 1999-08-12 2000-07-24 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
IL147563A IL147563A (en) 1999-08-12 2002-01-10 POLYNUCLEOTIDE MOLECULE COMPRISING A STREPTOMYCES AVERMITILIS MUTATED AveC ALLELE DIRECTING THE RATIO OF B2:B1 AVERMECTINS AND METHOD OF PRODUCING THE SAME

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147563A IL147563A (en) 1999-08-12 2002-01-10 POLYNUCLEOTIDE MOLECULE COMPRISING A STREPTOMYCES AVERMITILIS MUTATED AveC ALLELE DIRECTING THE RATIO OF B2:B1 AVERMECTINS AND METHOD OF PRODUCING THE SAME

Country Status (39)

Country Link
US (3) US6632673B1 (cs)
EP (1) EP1200606B1 (cs)
JP (1) JP3884651B2 (cs)
KR (1) KR100489856B1 (cs)
CN (1) CN1186446C (cs)
AP (1) AP2002002418A0 (cs)
AR (1) AR022646A1 (cs)
AT (1) ATE341632T1 (cs)
AU (1) AU778837B2 (cs)
BG (1) BG65902B1 (cs)
BR (1) BRPI0013119B8 (cs)
CA (1) CA2380872C (cs)
CO (1) CO5290295A1 (cs)
CY (1) CY1105778T1 (cs)
CZ (1) CZ304402B6 (cs)
DE (1) DE60031126T2 (cs)
DK (1) DK1200606T3 (cs)
EA (1) EA200200056A1 (cs)
ES (1) ES2272299T3 (cs)
GT (1) GT200000136A (cs)
HK (1) HK1046710B (cs)
HR (1) HRP20020130A2 (cs)
HU (1) HU230600B1 (cs)
IL (2) IL147563A0 (cs)
IS (1) IS6250A (cs)
MA (1) MA26813A1 (cs)
MX (1) MXPA02001513A (cs)
NO (1) NO20020664L (cs)
NZ (1) NZ516517A (cs)
OA (1) OA11998A (cs)
PA (1) PA8499501A1 (cs)
PE (1) PE20010690A1 (cs)
PL (1) PL203818B1 (cs)
PT (1) PT1200606E (cs)
SK (1) SK288086B6 (cs)
TN (1) TNSN00171A1 (cs)
UY (1) UY26286A1 (cs)
WO (1) WO2001012821A1 (cs)
ZA (1) ZA200201072B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60031126T2 (de) * 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
CN1630712B (zh) * 2002-02-12 2011-09-28 辉瑞产品公司 指导b2:b1除虫菌素比例的除虫链霉菌基因
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
KR102657859B1 (ko) 2021-04-07 2024-04-16 윤재식 일체형 내화 소켓

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
IN167980B (cs) * 1987-01-23 1991-01-19 Pfizer
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
EP0313297B1 (en) 1987-10-23 1993-05-19 Pfizer Inc. Process for production of avermectin aglycones and cultures therefor
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
EP0391594B1 (en) 1989-03-31 1995-10-18 Merck & Co. Inc. Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
WO1995004150A1 (en) 1993-07-30 1995-02-09 Pfizer Inc. Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
FI942725A7 (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
EP0964922A4 (en) 1996-09-27 2000-10-25 Maxygen Inc METHOD FOR OPTIMIZING GENE THERAPY BY REPEATING SEQUENCE MIXING AND SELECTION
EP1717322B1 (en) 1997-01-17 2012-07-18 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
NZ518657A (en) * 1998-02-13 2003-10-31 Pfizer Prod Inc Streptomyces hygroscopicus directing the ratio of B2:B1 avermectins
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
DE60031126T2 (de) * 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen

Also Published As

Publication number Publication date
PA8499501A1 (es) 2001-12-14
PE20010690A1 (es) 2001-07-06
NZ516517A (en) 2003-10-31
HUP0202487A2 (en) 2002-10-28
JP3884651B2 (ja) 2007-02-21
KR20020029379A (ko) 2002-04-18
OA11998A (en) 2006-04-18
ES2272299T3 (es) 2007-05-01
CA2380872C (en) 2007-11-27
CO5290295A1 (es) 2003-06-27
SK1392002A3 (en) 2002-12-03
UY26286A1 (es) 2001-03-16
BR0013119B1 (pt) 2014-02-25
CN1186446C (zh) 2005-01-26
HRP20020130A2 (en) 2003-06-30
US6632673B1 (en) 2003-10-14
ATE341632T1 (de) 2006-10-15
BRPI0013119B8 (pt) 2021-05-25
CN1373809A (zh) 2002-10-09
EP1200606B1 (en) 2006-10-04
GT200000136A (es) 2002-02-01
JP2003507017A (ja) 2003-02-25
KR100489856B1 (ko) 2005-05-17
CA2380872A1 (en) 2001-02-22
PL203818B1 (pl) 2009-11-30
HU230600B1 (hu) 2017-02-28
DE60031126T2 (de) 2007-02-08
PL353874A1 (en) 2003-12-01
HK1046710A1 (en) 2003-01-24
DK1200606T3 (da) 2007-01-08
CZ2002296A3 (cs) 2002-08-14
EP1200606A1 (en) 2002-05-02
CY1105778T1 (el) 2011-02-02
AU5838600A (en) 2001-03-13
SK288086B6 (sk) 2013-06-03
TNSN00171A1 (fr) 2005-11-10
AR022646A1 (es) 2002-09-04
DE60031126D1 (de) 2006-11-16
PT1200606E (pt) 2006-12-29
MXPA02001513A (es) 2002-07-02
HK1046710B (zh) 2005-05-13
MA26813A1 (fr) 2004-12-20
IS6250A (is) 2002-01-25
NO20020664D0 (no) 2002-02-11
CZ304402B6 (cs) 2014-04-16
ZA200201072B (en) 2003-04-30
AP2002002418A0 (en) 2002-03-31
US20030232415A1 (en) 2003-12-18
EA200200056A1 (ru) 2002-06-27
HUP0202487A3 (en) 2004-07-28
BG65902B1 (bg) 2010-04-30
NO20020664L (no) 2002-02-11
US20040009560A1 (en) 2004-01-15
IL147563A (en) 2009-06-15
WO2001012821A1 (en) 2001-02-22
BG106479A (bg) 2002-10-31
AU778837B2 (en) 2004-12-23
BR0013119A (pt) 2002-04-23
US7858340B2 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
AU3330700A (en) Novel cytidine deaminase
AU5515901A (en) Gamma-phosphoester nucleoside triphosphates
IL156561A0 (en) Macrolide antibiotics
AU2001272719A1 (en) Macrolide antibiotics
IL144178A0 (en) Ketolide antibiotics
AU2001278694A1 (en) Avermectin derivatives
AU2203801A (en) Formulations of adenosine a1 agonists
AU2203601A (en) Formulations of adenosine a1 agonists
HU9903073D0 (en) Streptomyces avermitilis regulatory genes for increased avermectin production
IL147562A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
HUP0100784A3 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
HUP0202487A3 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
AU5789001A (en) Macrolide antiinfective agents
TWI341330B (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
EP1206477A4 (en) CLONING OF THE STREPTOMYCES AVERMITILIS GENES FOR THE GLYCOSYLATION OF AVERMECTIN AGLYCONES
AU1974900A (en) Macrolide intermediates in the preparation of clarithromycin
AU2204001A (en) Formulations of adenosine a1 agonists
AU4808200A (en) Dna balls
AU2690500A (en) Avermectin aglycon synthase genes
AU2208301A (en) Formulations of adenosine a1 agonists
AU2002215965A1 (en) Pyranoside derivatives
AU2001277712A1 (en) Avermectin derivatives
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU2002323990A1 (en) Adenosine derivatives